Long-term use of subcutaneous octreotide reduces variceal bleeding in non-cirrhotic portal hypertension
{{output}}
Background: Non-cirrhotic portal hypertension from a portal vein thrombus can cause variceal bleeding. The use of vasoactive agents such as octreotide is currently limited to acute bleeding episodes. Current strategies to reduce ... ...
